These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 4282968)

  • 21. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes.
    Ma BI; Joseph BS; Walsh MJ; Potvin AR; Tourtellotte WW
    Ann Neurol; 1981 Apr; 9(4):371-7. PubMed ID: 6452854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of cross-reactive antibodies to myelin and viral antigens in multiple sclerosis.
    Bernard CC; Townsend E
    Prog Clin Biol Res; 1984; 146():215-22. PubMed ID: 6201892
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific IgG autoantibodies are potent inhibitors of autoreactive T cell response to phytohemagglutinin-activated T cells.
    Wolf-Levin R; Azuma T; Aoki K; Yagami Y; Okada H
    J Immunol; 1993 Nov; 151(10):5864-77. PubMed ID: 8228265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic studies of chronic relapsing EAE in guinea pigs: similarities to multiple sclerosis.
    Mehta PD; Lassmann H; Wisniewski HM
    J Immunol; 1981 Jul; 127(1):334-8. PubMed ID: 7240747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of the serum and C.S.F. immunoglobulin fractions in multiple sclerosis.
    Cazzullo CL; Smeraldi E; Zibetti A
    Boll Ist Sieroter Milan; 1973; 52(2):142-9. PubMed ID: 4749293
    [No Abstract]   [Full Text] [Related]  

  • 26. IgG-antibodies to CNS proteins in patients with multiple sclerosis.
    Kaiser R; Obert M; Kaufmann R; Czygan M
    Eur J Med Res; 1997 Apr; 2(4):169-72. PubMed ID: 9110924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune reactivity to brain and viral antigens in multiple sclerosis patients: detection by the leucocyte adherence inhibition assay.
    Mayer M; Opavský J; Bártová A
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():277-83. PubMed ID: 6085908
    [No Abstract]   [Full Text] [Related]  

  • 28. CNS IgG synthesis in multiple sclerosis: choosing the right reference population.
    Shugar G
    Am J Clin Pathol; 1983 Jan; 79(1):144-5. PubMed ID: 6849294
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluorescent protein tracing in multiple sclerosis brain tissue.
    Simpson JF; Tourtellotte WW; Kokmen E; Parker JA; Itabashi HH
    Arch Neurol; 1969 Apr; 20(4):373-7. PubMed ID: 4894357
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoglobulin abnormalities in multiple sclerosis.
    Link H
    Ann Clin Res; 1973 Oct; 5(5):330-6. PubMed ID: 4209372
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis.
    Zéphir H; Lefranc D; Dubucquoi S; de Seze J; Boron L; Prin L; Vermersch P
    Mult Scler; 2009 May; 15(5):593-600. PubMed ID: 19299435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cerebrospinal fluid and serum of patients with multiple sclerosis by means of anti-idiotypic antisera.
    Nagelkerken LM; van Zoonen-van Exel M; van Walbeek HK; Aalberse RC; Out TA
    J Immunol; 1982 Mar; 128(3):1102-6. PubMed ID: 6173419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of lymphoblast formation by IgG Serum fraction of M.S. patients.
    Chinen A; Yokoyama MM
    Z Immunitatsforsch Exp Klin Immunol; 1973 Nov; 146(2):101-7. PubMed ID: 4282968
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.